Chester County News and Community Website
EXTON, PA — West Pharmaceutical Services, Inc. (NYSE: WST) will release its first-quarter financial results before the market opens on Thursday, April 24, 2025, followed by a conference call at …
West Pharmaceutical Services to Announce Q1 2025 Results with Live Webcast and Q&A Session Read More
WAYNE, PA — Ecovyst Inc. (NYSE: ECVT) has announced plans to hold a conference call and audio-only webcast on Thursday, May 1, 2025, at 11:00 a.m. Eastern Time to discuss …
Ecovyst Inc. to Host Q1 2025 Earnings Call and Webcast on May 1 Read More
MALVERN, PA — Vishay Precision Group, Inc. (NYSE: VPG) will release its Q1 fiscal 2025 financial results before market open on Tuesday, May 6, 2025.
Vishay Precision Group to Announce Q1 FY2025 Results on May 6, 2025 Read More
MALVERN, PA — Endo, Inc. (OTCQX: NDOI) has announced it will release its first-quarter 2025 financial results on Wednesday, May 7, 2025, before the market opens.
Endo, Inc. to Release Q1 2025 Financial Results Read More
MALVERN, PA — CubeSmart (NYSE: CUBE) has announced that it will release its financial results for the first quarter ending March 31, 2025, following the market close on Thursday, May …
CubeSmart to Announce Q1 2025 Financial Results Read More
WAYNE, PA — Palvella Therapeutics, Inc. (Nasdaq: PVLA), a biopharmaceutical company focused on developing treatments for rare genetic skin diseases, has announced its financial results for 2024, alongside key corporate and …
Palvella Therapeutics Reports 2024 Financial Results and Advances Rare Disease Pipeline Read More
MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) has updated its financial results for the fourth quarter and full-year ending December 31, 2024, reflecting revisions related to its acquisition of Greenbrook TMS …
Neuronetics Revises Financial Results for Q4 and Full Year 2024 Read More
MALVERN, PA — Annovis Bio Inc. (NYSE: ANVS) has shared its corporate updates and financial results for the fourth quarter and full year of 2024, highlighting significant advancements in its clinical …
Annovis Bio Reports Progress in Clinical Trials and Improved Financial Position Read More
MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) has reported its financial results for the fourth quarter and full year 2024. The company showcased a year of steady growth and operational …
TELA Bio Announces 2024 Financial Results and Positive 2025 Outlook Read More WAYNE, PA — Palvella Therapeutics, Inc. (Nasdaq: PVLA) has announced it will release its full-year 2024 financial results on Monday, March 31, 2025. The company will also host a conference …
Palvella Therapeutics to Announce 2024 Financial Results and Host Investor Call on March 31, 2025 Read More